• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 in patients with hematological malignancies: A retrospective case series.血液系统恶性肿瘤患者中的新型冠状病毒肺炎：一项回顾性病例系列研究。
Int J Lab Hematol. 2020 Dec;42(6):e256-e259. doi: 10.1111/ijlh.13301. Epub 2020 Aug 4.
2
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
3
Managing patients with hematological malignancies during COVID-19 pandemic.在新冠疫情期间管理血液系统恶性肿瘤患者
Expert Rev Hematol. 2020 Aug;13(8):787-793. doi: 10.1080/17474086.2020.1787147. Epub 2020 Jul 12.
4
Prolonged shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) RNA among patients with coronavirus disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）RNA的长期脱落
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1235-1236. doi: 10.1017/ice.2020.307. Epub 2020 Jun 24.
5
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.血液恶性肿瘤和癌症治疗类型对 COVID-19 严重程度和死亡率的影响：一项大型基于人群的登记研究的经验教训。
J Hematol Oncol. 2020 Oct 8;13(1):133. doi: 10.1186/s13045-020-00970-7.
6
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
7
Intra-arterial thrombosis associated with COVID-19.与新型冠状病毒肺炎相关的动脉内血栓形成
J Vasc Surg. 2020 Aug;72(2):757-758. doi: 10.1016/j.jvs.2020.05.019. Epub 2020 May 17.
8
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者入院时的循环纤溶酶原浓度
Semin Thromb Hemost. 2020 Oct;46(7):859-862. doi: 10.1055/s-0040-1715454. Epub 2020 Sep 3.
9
Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020.2020 年 4 月，西班牙巴塞罗那疗养院中无症状的 SARS-CoV-2 感染。
Emerg Infect Dis. 2020 Sep;26(9):2281-3. doi: 10.3201/eid2609.202603. Epub 2020 Jun 23.
10
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.隔离一艘游轮上的乘客后，其体内的 SARS-CoV-2 脱落和血清转化：一项病例系列研究。
Lancet Infect Dis. 2020 Sep;20(9):1051-1060. doi: 10.1016/S1473-3099(20)30364-9. Epub 2020 Jun 12.

引用本文的文献

1
COVID-19 in Adult Patients with Hematological Malignancies-Lessons Learned after Three Years of Pandemic.血液系统恶性肿瘤成年患者中的COVID-19——大流行三年后的经验教训
Biology (Basel). 2023 Apr 3;12(4):545. doi: 10.3390/biology12040545.
2
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).接受靶向药物治疗的B细胞恶性肿瘤与SARS-CoV-2感染：一项欧洲血液学协会调查（EPICOVIDEHA）
Front Oncol. 2022 Oct 3;12:992137. doi: 10.3389/fonc.2022.992137. eCollection 2022.
3
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.预测 SARS-CoV-2 感染在血液病患者中的临床演变的因素：系统评价和荟萃分析。
Hematol Oncol. 2023 Feb;41(1):16-25. doi: 10.1002/hon.3084. Epub 2022 Oct 20.
4
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).2021 年欧洲白血病感染会议（ECIL 9）关于血液系统恶性肿瘤或造血细胞移植患者 COVID-19 管理的建议。
Leukemia. 2022 Jun;36(6):1467-1480. doi: 10.1038/s41375-022-01578-1. Epub 2022 Apr 29.
5
Challenges posed by COVID-19 in cancer patients: A narrative review.COVID-19 对癌症患者带来的挑战：一篇叙述性综述。
Cancer Med. 2022 Feb;11(4):1119-1135. doi: 10.1002/cam4.4519. Epub 2021 Dec 23.
6
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review.淋巴瘤患者中的新型冠状病毒肺炎（严重急性呼吸综合征冠状病毒2感染）：综述
World J Virol. 2021 Nov 25;10(6):312-325. doi: 10.5501/wjv.v10.i6.312.
7
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).COVID-19 感染成年血液病患者：欧洲血液学协会调查（EPICOVIDEHA）。
J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.
8
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.COVID-19 感染 96 例血液系统疾病患者：来自捷克共和国的首个单中心经验。
Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):606-612. doi: 10.1016/j.clml.2021.04.016. Epub 2021 May 31.
9
Impact of COVID-19 in patients with lymphoid malignancies.新型冠状病毒肺炎对淋巴系统恶性肿瘤患者的影响。
World J Virol. 2021 May 25;10(3):97-110. doi: 10.5501/wjv.v10.i3.97.
10
Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer.金属结合苯并咪唑衍生物的表征及其对肺癌肿瘤细胞的影响
Materials (Basel). 2021 May 30;14(11):2958. doi: 10.3390/ma14112958.

本文引用的文献

1
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.血液系统恶性肿瘤的COVID-19患者中SARS-CoV-2 RNA的不良预后和长期持续存在；国王学院医院的经验。
Br J Haematol. 2020 Sep;190(5):e279-e282. doi: 10.1111/bjh.16935. Epub 2020 Aug 10.
2
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.血液肿瘤患者中2019冠状病毒病的临床结局
Br J Haematol. 2020 Jul;190(2):e64-e67. doi: 10.1111/bjh.16852. Epub 2020 Jun 10.
3
Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.新冠病毒病与血液系统恶性肿瘤并存的住院患者生存研究
Br J Haematol. 2020 Jul;190(1):e16-e20. doi: 10.1111/bjh.16801. Epub 2020 May 27.
4
COVID-19 outcomes in patients with hematologic disease.血液系统疾病患者的新型冠状病毒肺炎结局
Bone Marrow Transplant. 2020 Nov;55(11):2180-2184. doi: 10.1038/s41409-020-0931-4. Epub 2020 May 6.
5
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.评估封锁措施的影响：COVID-19大流行期间血液学患者护理面临的新挑战。
Br J Haematol. 2020 Jun;189(6):e224-e227. doi: 10.1111/bjh.16782. Epub 2020 May 23.
6
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
7
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.纽约医院系统中 COVID-19 癌症患者的病死率。
Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1.
8
COVID-19 in persons with haematological cancers.COVID-19 与血液系统恶性肿瘤。
Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24.
9
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
10
COVID-19 and the clinical hematology laboratory.新型冠状病毒肺炎与临床血液学实验室
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):11-18. doi: 10.1111/ijlh.13229.

COVID-19 in patients with hematological malignancies: A retrospective case series.

作者信息

Infante Maria-Stefania, González-Gascón Y Marín Isabel, Muñoz-Novas Carolina, Churruca Juan, Foncillas María-Ángeles, Landete Elena, Marín Karen, Ryan Pablo, Hernández-Rivas José-Ángel

机构信息

Hematology Department, University Hospital Infanta Leonor, Madrid, Spain.

Universidad Complutense de Madrid, Madrid, Spain.

出版信息

Int J Lab Hematol. 2020 Dec;42(6):e256-e259. doi: 10.1111/ijlh.13301. Epub 2020 Aug 4.

DOI:10.1111/ijlh.13301
PMID:32749757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7435496/
Abstract
摘要